Coordinating epidermal growth factor-induced motility promotes efficient wound closure.
Wound healing is a response to injury that is initiated to reconstruct damaged tissue. In skin, reepithelialization involves both epithelial cells and fibroblasts and contributes to the reformation of a barrier between the external environment and internal milieu. Growth factors including epidermal growth factor (EGF) play important roles in promoting this process. In the present studies we employed CV-1 fibroblasts in a tissue culture model of reepithelialization to develop strategies for optimizing wound closure stimulated by EGF. We found that EGF enhanced cell motility within 6-8 h of EGF treatment in serum-free medium but wounds failed to close within 24 h. However, if medium on these cultures was exchanged for medium containing serum, cells pretreated with EGF closed new scrape wounds more rapidly than did cells that were not pretreated. These results indicate that serum factors work in concert with EGF to coordinate cell motility for efficient wound closure. Indeed, EGF enhanced the rate of wound closure in the presence of serum, and this effect also persisted for at least 24 h after EGF was removed. This coordination of EGF-induced cell motility was accompanied by an increase in the transient phosphorylation of ERK1 and ERK2. The persistent effects of EGF were blocked by transient exposure to reversible inhibitors of transcription and translation, indicating that the expression of new proteins mediated this response. We propose that EGF-stimulated CV-1 fibroblast motility is coordinated by a serum component that induces cell-cell adhesive properties consistent with an epithelial phenotype, thereby enhancing the reepithelialization process.
Kurten
Richard C
RC
Department of Physiology & Biophysics, University of Arkansas for Medical Sciences, Little Rock 72205-0750, USA. KurtenRichardC@uams.edu <KurtenRichardC@uams.edu>
Chowdhury
Parag
P
Sanders
Ronald C
RC
Pittman
Laura M
LM
Sessions
Laura W
LW
Chambers
Timothy C
TC
Lyle
Christopher S
CS
Schnackenberg
Bradley J
BJ
Jones
Stacie M
SM
D000818:Animals; D001798:Blood Proteins / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects*; D002478:Cells, Cultured; D002522:Chlorocebus aethiops; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D004847:Epithelial Cells / Q000166:cytology; D005347:Fibroblasts / Q000166:cytology; D007668:Kidney / Q000166:cytology; D014945:Wound Healing / Q000187:drug effects*
D001798:Blood Proteins; D004815:Epidermal Growth Factor